Lives unaffected by cystic fibrosis


Back to the Drug Development Pipeline


To Patients

To Patients

Therapeutic Approach


AquaADEKs® is an oral antioxidant vitamin formulation specifically for people with CF.


A clinical trial that ended in 2008 assessed the safety and ability of this formulation to increase blood levels of antioxidants, normalize plasma levels of fat-soluble vitamins, improve pulmonary function and improve growth parameters. Vitamin levels significantly increased and signs of inflammation were reduced.

Researchers have also conducted a Phase 2 study to see if AquADEKs may have an effect on inflammation and oxidative stress in people with CF ages 10 and older. 


The program is sponsored in the US by Yasoo Health, Inc and partially funded by Cystic Fibrosis Foundation Therapeutics (CFFT). It was conducted within CFFT's Therapeutics Development Network.

Contact us about AquADEKs® >